Pre-seed · Healthtech
MediKno secures pre-seed investment from build3
The dermatology software company plans to expand clinical deployments and develop its AI tools.
MediKno announced a pre-seed investment from build3 on June 23, 2026. The company did not disclose the amount.
It planned to use the financing for AI and product development, clinical deployments and partnerships with dermatologists and healthcare providers. Its tools combine skin and hair screening support with records, prescriptions and clinic administration.
The investment adds a venture-building partner as MediKno works to bring its tools into clinical use. The company said it was also speaking with further investors as part of its continuing pre-seed round.
Use of funds
AI and product development
Clinical deployments
Healthcare partnerships
Funding history
Pre-seed · This roundUndisclosed